Tubulocystic Renal Cell Carcinoma
1 clinical trials · Condition
◉ Watch Tubulocystic Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer (NCT04603365) | Jonsson Comprehensive Cancer Center | 2021-10-18 |
Track Tubulocystic Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.